The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, X. C.
Right arrow Articles by Strom, T. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, X. C.
Right arrow Articles by Strom, T. B.
The Journal of Immunology, 1999, 163: 2500-2507.
Copyright © 1999 by The American Association of Immunologists

Induction of Allograft Tolerance in the Absence of Fas-Mediated Apoptosis1

Xian Chang Li2,*, Yongsheng Li2,*, Ingrid Dodge*, Andrew D. Wells{dagger}, Xin Xiao Zheng*, Laurence A. Turka{dagger} and Terry B. Strom3,*

* Department of Medicine, Harvard Medical School, Division of Immunology, Beth Israel Deaconess Medical Center, Boston, MA 02215; and {dagger} Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104

Using certain immunosuppressive regimens, IL-2 knockout (KO) mice, in contrast to wild-type (wt) controls, are resistant to the induction of allograft tolerance. The mechanism by which IL-2 regulates allograft tolerance is uncertain. As IL-2 KO mice have a profound defect in Fas-mediated apoptosis, we hypothesized that Fas-mediated apoptosis of alloreactive T cells may be critical in the acquisition of allograft tolerance. To definitively study the role of Fas in the induction of transplantation tolerance, we used Fas mutant B6.MRL-lpr mice as allograft recipients of islet and vascularized cardiac transplants. Alloantigen-stimulated proliferation and apoptosis of Fas-deficient cells were also studied in vivo. Fas mutant B6.MRL-lpr (H-2b) mice rapidly rejected fully MHC-mismatched DBA/2 (H-2d) islet allografts and vascularized cardiac allografts with a tempo that is comparable to wt control mice. Both wt and B6.MRL-lpr mice transplanted with fully MHC-mismatched islet allografts or cardiac allografts can be readily tolerized by either rapamycin or combined costimulation blockade (CTLA-4Ig plus anti-CD40L mAb). Despite the profound defect of Fas-mediated apoptosis, Fas-deficient T cells can still undergo apoptotic cell death in vivo in response to alloantigen stimulation. Our study suggests that: 1) Fas is not necessarily essential for allograft tolerance, and 2) Fas-mediated apoptosis is not central to the IL-2-dependent mechanism governing the acquisition of allograft tolerance.




This article has been cited by other articles:


Home page
BloodHome page
J.-G. Chai, E. James, H. Dewchand, E. Simpson, and D. Scott
Transplantation tolerance induced by intranasal administration of HY peptides
Blood, May 15, 2004; 103(10): 3951 - 3959.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Sandalova, C.-H. Wei, M. G. Masucci, and V. Levitsky
Regulation of expression of Bcl-2 protein family member Bim by T cell receptor triggering
PNAS, March 2, 2004; 101(9): 3011 - 3016.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. van Maurik, B. F. de St. Groth, K. J. Wood, and N. D. Jones
Dependency of Direct Pathway CD4+ T Cells on CD40-CD154 Costimulation Is Determined by Nature and Microenvironment of Primary Contact with Alloantigen
J. Immunol., February 15, 2004; 172(4): 2163 - 2170.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. R. Rao, M. P. Quinones, E. Garavito, Y. Kalkonde, F. Jimenez, C. Gibbons, J. Perez, P. Melby, W. Kuziel, R. L. Reddick, et al.
CC Chemokine Receptor 2 Expression in Donor Cells Serves an Essential Role in Graft-versus-Host-Disease
J. Immunol., November 1, 2003; 171(9): 4875 - 4885.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Demirci, T. B. Strom, and X. C. Li
Islet Allograft Rejection in Nonobese Diabetic Mice Involves the Common {gamma}-Chain and CD28/CD154-Dependent and -Independent Mechanisms
J. Immunol., October 1, 2003; 171(7): 3878 - 3885.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Gonzalez, A. Orlofsky, and M. B. Prystowsky
A1 is a growth-permissive antiapoptotic factor mediating postactivation survival in T cells
Blood, April 1, 2003; 101(7): 2679 - 2685.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X.-Z. Yu, P. J. Martin, and C. Anasetti
CD28 Signal Enhances Apoptosis of CD8 T Cells After Strong TCR Ligation
J. Immunol., March 15, 2003; 170(6): 3002 - 3006.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Quemeneur, M. Flacher, L.-M. Gerland, M. Ffrench, J.-P. Revillard, and N. Bonnefoy-Berard
Mycophenolic Acid Inhibits IL-2-Dependent T Cell Proliferation, But Not IL-2-Dependent Survival and Sensitization to Apoptosis
J. Immunol., September 1, 2002; 169(5): 2747 - 2755.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-H. Wei, H. Yagita, M. G. Masucci, and V. Levitsky
Different Programs of Activation-Induced Cell Death Are Triggered in Mature Activated CTL by Immunogenic and Partially Agonistic Peptide Ligands
J. Immunol., January 15, 2001; 166(2): 989 - 995.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
P. J. Blair, J. L. Riley, D. M. Harlan, R. Abe, D. K. Tadaki, S. C. Hoffmann, L. White, T. Francomano, S. J. Perfetto, A. D. Kirk, et al.
CD40 Ligand (CD154) Triggers a Short-Term CD4+ T Cell Activation Response That Results in Secretion of Immunomodulatory Cytokines and Apoptosis
J. Exp. Med., February 21, 2000; 191(4): 651 - 660.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.